Chinese medical device manufacturer Meihua International Medical Technologies became the first China-based firm to list in the US since the ill-fated Didi Global IPO in July, reports Bloomberg. Meihua sold 3.6 million shares, fewer than it had originally proposed, for $10 each on Wednesday to raise $36 million, according to a statement. It had marketed as many as 5 million shares for $9 to $11.
At the IPO price, Meihua would have a market value of $236 million based on the outstanding shares listed in its filings with the US Securities and Exchange Commission. A successful share sale by the medical device maker would break the impasse for Chinese companies seeking to go public in the US.
Ride-hailing service Didi—over the objections of regulators in China—raised $4.44 billion in an IPO in June. Regulators in China announced a cybersecurity probe into the firm and banned it from adding new customers, marking the beginning of a broader crackdown that wiped more than $1 trillion in value from US-listed Chinese stocks. Since then, Beijing unveiled sweeping new rules tightening scrutiny over firms listing abroad in an attempt to prevent the leakage of sensitive data.
You must log in to post a comment.